Original articleThe relationship between glycemic control and platelet activity in type 2 diabetes mellitus
Introduction
Type 2 diabetes mellitus (DM) is characterized mainly by tissue insulin resistance and impaired insulin secretion. Increased platelet activity due to abnormal insulin action is emphasized in the development of vascular complications of this disease (Vinik, Erbas, Park, Nolan, & Pittneger, 2001). Platelet activity and aggregation potential, which are essential in atherogenesis and thrombogenesis, can be easily estimated by measuring mean platelet volume (MPV) as part of whole blood count (Bancroft et al., 2000, Bath & Butterworth, 1996, Sharpe & Trinick, 1993, Thompson & Jakubowski, 1983). Large platelets are more active than smaller platelets and produce more prothrombotic factors such as thromboxane A2. This indicates that changes in the platelet count and MPV reflect the state of thrombogenesis (Bath & Butterworth, 1996, Bancroft et al., 2000, Thompson & Jakubowski, 1983). It has been reported that the increase of MPV in the late phase of myocardial infarction is an independent predictor for recurrent myocardial infarction (Hendra, Oswald, & Yudkin, 1988).
Previous studies demonstrated that poor glycemic control was associated with increased diabetic micro- and macrovascular complications (Stettler et al., 2006). It has been shown that MPV was significantly higher in diabetic populations (Sharpe & Trinick, 1993, Tschope et al., 1989, Winocour, 1994); however, the influence of glycemic control on MPV has not been investigated. Starting out from this point, we hypothesized that the increased risk of diabetic vascular complications in patients with poor glycemic control may be related to impaired platelet function and activity, which may be recovered by tight glycemic control. Therefore, the aim of this study was to assess not only the association among MPV, glycemic control, and diabetic vascular complications but also the influence of improved glycemic control on MPV in type 2 diabetic patients.
Section snippets
Patients and methods
A total of 70 type 2 diabetic patients (56 females and 14 males; age, 55.1±10.2 years; range, 32–78 years) were enrolled. The mean (±S.D.) duration of diabetes was 5.9±4.8 years. Diabetic patients were evaluated for metabolic regulation of diabetes, nephropathy, retinopathy, neuropathy, and coronary artery disease (CAD). Twenty (29%) patients had known proliferative diabetic retinopathy treated by photocoagulation, 22 (7.58%) of them had microalbuminuria, 24 (34%) had polyneuropathy, and 9
Results
When we compared 70 patients with type 2 DM and 40 healthy controls, MPV levels were significantly higher in patients with diabetes (8.7±0.8 fl vs. 8.2±0.7 fl, P=.002). There was no statistical difference between the two groups with regard to BMI, age, sex, diastolic BP, creatinine, creatine clearance, platelet count, and platelet mass. Patients with diabetes had a higher systolic BP, total cholesterol, LDL-C, HDL-C, triglycerides, albuminuria, and fasting blood glucose. We found a significant
Discussion
Our study has several important findings. MPV, a marker of platelet function and activation, was significantly higher in patients with type 2 diabetes than in controls. We also found that platelet activity was significantly higher in patients with HbA1c levels >7% than in patients with HbA1c levels ≤7%. Another important finding is that MPV was significantly decreased in patients with poor glycemic control after achieving improved glycemic control. Previous studies have shown that MPV increased
References (29)
- et al.
Mean platelet volume in type 2 diabetic patients
Journal of Diabetes and its Complications
(2004, May–June) - et al.
Increased mean platelet volume after acute myocardial infarction relates to diabetes and to cardiac failure
Diabetes research and Clinical Practice
(1988) - et al.
Mean platelet volume on admission predicts impaired reperfusion and long-term mortality in acute myocardial infarction treated with primary percutaneous coronary intervention
Journal of the American College of Cardiology
(2005, July) - et al.
Glycemic control and macrovascular disease in types 1 and 2 diabetes mellitus: Meta-analysis of randomized trials
American Heart Journal
(2006) - et al.
Mean platelet volume as marker of restenosis after percutaneous transluminal coronary angioplasty in patients with stable and unstable angina pectoris
Thrombosis Research
(2006) - et al.
Thromboxane biosynthesis and platelet function in type I diabetes mellitus
New England Journal of Medicine
(1988) - et al.
The treatment of hypertension in adult patients with diabetes
Diabetes Care
(2002) - et al.
The relationship between mean platelet volume, in-vitro platelet function tests and microvascular complications in type 2 diabetes mellitus
Turk Hematoloji Onkoloji Dergisi
(2004) - et al.
Mean platelet volume is a useful parameter: A reproducible routine method using a modified Coulter thrombocytometer
Platelets
(2000) - et al.
Platelet size: Measurement, physiology and vascular disease
Blood Coagulation & Fibrinolysis
(1996)
Increased platelet volume and platelet mass in patients with atherosclerotic renal artery stenosis
Clinical Science
Platelet function defects: A clinical review
Seminars in Thrombosis and Hemostasis
The effect of pre-eclampsia on complete blood count, platelet count and mean platelet volume
Annals of Hematology
Methods for monitoring platelet function
American Heart Journal
Cited by (140)
Relationships between diabetes-related vascular risk factors and neurodegeneration biomarkers in healthy aging and Alzheimer's disease
2022, Neurobiology of AgingCitation Excerpt :Several studies have shown that increased glycemia levels contribute to increased platelet activity in non-diabetic and diabetic individuals (Kaur et al., 2018; Keating et al., 2003; Shilpi & Potekar, 2018; Zaccardi et al., 2017). Increased platelet activity in diabetic individuals is involved in the development of vascular complications and higher cardiovascular risk (Chen et al., 2017; Demirtunc et al., 2009). This increased platelet activity has been also largely described as an important vascular risk factor involved in AD progression (Liang et al., 2014; Wang et al., 2013; Wu et al., 2021; Yesil et al., 2012).
Evaluation of correlation between glycated hemoglobin and hematological indices in type 2 diabetes mellitus patients
2021, International Journal of Pharmaceutical Sciences and ResearchPlatelet-associated biomarkers in nonalcoholic steatohepatitis: Insights from a female cohort with obesity
2024, European Journal of Clinical InvestigationA Comparative Study of Mean Platelet Volume in Diabetic Population With and Without Vascular Complication
2023, Indonesian Journal of Medical Laboratory Science and TechnologyMean platelet volume for differentiating non-alcoholic fatty liver disease from non-alcoholic steatohepatitis: Is it ready for prime time?
2023, Indian Journal of Gastroenterology